SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-050947
Filing Date
2011-03-01
Accepted
2011-03-01 06:59:53
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 6809176
2 ARTICLES OF ASSOCIATION (STATUTS) OF SANOFI-AVENTIS (ENGLISH TRANSLATION) dex11.htm EX-1.1 43894
3 BOARD CHARTER (REGLEMENT INTERIEUR) OF SANOFI-AVENTIS (ENGLISH TRANSLATION) dex12.htm EX-1.2 68813
4 CERTIFICATION OF CHRISTOPHER VIEHBACHER, CEO, REQUIRED BY SECTION 302. dex121.htm EX-12.1 10340
5 CERTIFICATION OF JEROME CONTAMINE, PFO, REQUIRED BY SECTION 302. dex122.htm EX-12.2 10454
6 CERTIFICATION OF CHRISTOPHER VIEHBACHER, CEO, REQUIRED BY SECTION 906. dex131.htm EX-13.1 3939
7 CERTIFICATION OF JEROME CONTAMINE, PFO, REQUIRED BY SECTION 906. dex132.htm EX-13.2 4072
8 CONSENT OF ERNST & YOUNG AUDIT dex231.htm EX-23.1 2309
9 CONSENT OF PRICEWATERHOURSECOOPERS AUDIT dex232.htm EX-23.2 2296
10 REPORT OF THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR 2010. dex991.htm EX-99.1 72077
  Complete submission text file 0001193125-11-050947.txt   7028840
Mailing Address 174 AVENUE DE FRANCE PARIS I0 75013
Business Address 174 AVENUE DE FRANCE PARIS I0 75013 33153774400
SANOFI-AVENTIS (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-31368 | Film No.: 11648932
SIC: 2834 Pharmaceutical Preparations